Final 5-year study results of DASISION: The dasatinib versus imatinib study in treatment-Naïve chronic myeloid leukemia patients trial

Jorge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiří Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luis Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus

Research output: Contribution to journal › Article › peer-review

685 Scopus citations

Fingerprint

Dive into the research topics of 'Final 5-year study results of DASISION: The dasatinib versus imatinib study in treatment-Naïve chronic myeloid leukemia patients trial'. Together they form a unique fingerprint.

Medicine & Life Sciences